Search

In Stock

Buy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate) Online

DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease

MANUFACTURER: AstraZeneca Pharmaceuticals LP

USAGE: Oral

MEDICINE APPROVED BY:

Food and Drug Administration (FDA)

Pharmaceuticals and Medical Devices Agency (PMDA)

 

Breztri Aerosphere is a pharmaceutical medication that is primarily used for the treatment of chronic obstructive pulmonary disease (COPD). This medication is designed to provide relief and management of the symptoms associated with COPD, which includes chronic bronchitis and emphysema.

$305.35

Clear
Compare

Breztri Aerosphere is a pharmaceutical medication that is primarily used for the treatment of chronic obstructive pulmonary disease (COPD). This medication is designed to provide relief and management of the symptoms associated with COPD, which includes chronic bronchitis and emphysema.

Here is a detailed description of Breztri Aerosphere:

Name: Breztri Aerosphere

Active Ingredients: Breztri Aerosphere contains three active ingredients: budesonide, glycopyrrolate, and formoterol fumarate. These components work together to address different aspects of COPD symptoms.

  • Budesonide: Budesonide is a corticosteroid that helps reduce inflammation in the airways. By decreasing inflammation, it can make it easier to breathe and reduce the risk of exacerbations.
  • Glycopyrrolate: Glycopyrrolate is an anticholinergic bronchodilator. It helps relax and widen the airways, making it easier for air to flow in and out of the lungs.
  • Formoterol Fumarate: Formoterol fumarate is a long-acting beta-agonist bronchodilator. It helps to relax and open the air passages in the lungs, making it easier for individuals with COPD to breathe.

Dosage Forms: Breztri Aerosphere is typically available in the form of an inhaler, which delivers the medication directly to the lungs for optimal effectiveness.

Indications: Breztri Aerosphere is prescribed for adults with COPD to improve lung function and reduce symptoms, such as shortness of breath, coughing, and wheezing. It is not intended for use as a rescue inhaler and should be taken regularly as directed by a healthcare professional.

Usage: Patients are typically advised to inhale Breztri Aerosphere once daily at the same time each day, as prescribed by their healthcare provider. The inhaler should be used exactly as directed, and patients should not exceed the recommended dose.

Benefits: Breztri Aerosphere offers the advantage of combining three different types of medications in a single inhaler. This can simplify the treatment regimen for COPD patients by reducing the number of inhalers they need to manage their symptoms.

Precautions: Before using Breztri Aerosphere, it is crucial to consult with a healthcare provider. Patients should disclose any allergies, medical conditions, or other medications they are taking, as these factors can affect the safety and efficacy of the medication.

Side Effects: Like any medication, Breztri Aerosphere may cause side effects, which can vary from person to person. Common side effects may include headache, cough, or throat irritation. Serious side effects are rare but can include increased blood pressure, heart palpitations, and changes in blood glucose levels. Patients should promptly report any unusual or severe side effects to their healthcare provider.

In conclusion, Breztri Aerosphere is a prescription medication designed to manage and improve the symptoms of COPD. It combines three active ingredients to provide comprehensive relief by reducing inflammation and relaxing the airways. Patients should use it as prescribed and be aware of potential side effects while under the guidance of a healthcare professional.

Package

28 Inhalations

Reviews

There are no reviews yet.

Write a review

Your email address will not be published. Required fields are marked *

Bestsellers

Buy Yupelri (revefenacin) Online

(0 Reviews)
DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease MANUFACTURER: Theravance Biopharma USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA) Yupelri is a pharmaceutical medication used to treat chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by difficulty breathing, coughing, and wheezing.

Buy Tezspire (tezepelumab-ekko) Online

$6,696.25
(0 Reviews)
DISEASE INDICATIONS: Asthma MANUFACTURER: Amgen / AstraZeneca AB USAGE: Subcutaneous MEDICINE APPROVED BY: Food and Drug Administration (FDA)   Tezspire (tezepelumab-ekko) is a prescription medication that belongs to the drug class of monoclonal antibodies. It is used to treat severe asthma in adults and children 12 years of age and older whose condition cannot be managed by their existing asthma medication. Tezspire is the first and only biologic approved for severe asthma without phenotypic or biomarker limitations.

Buy Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor) Online

From $39,106.10
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals Incorporated USAGE: Oral MEDICINE APPROVED BY: Food and Drug Administration (FDA)   Trikafta is designed to address the underlying genetic mutations in individuals with CF and has been shown to significantly improve lung function and overall health in many patients.

Buy Orkambi (lumacaftor/ivacaftor) Online

From $10,806.14
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Therapeutic Goods Administration (TGA) This medication is designed to address the underlying cause of CF in individuals who have two copies of the F508del mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene, which is a common genetic mutation associated with CF.

Buy Symdeko (tezacaftor / ivacaftor) Online

$39,418.95
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) , Symdeko is indicated for the treatment of patients with CF who have specific genetic mutations that are responsive to these medications. This combination therapy addresses the underlying cause of CF by improving the function of the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) protein, which is often dysfunctional in CF patients.

Buy Kalydeco (ivacaftor) Online

From $7,241.59
(0 Reviews)
DISEASE INDICATIONS: Cystic Fibrosis MANUFACTURER: Vertex Pharmaceuticals (Europe) Ltd USAGE: Oral MEDICINE APPROVED BY: European Medical Agency (EMA) Food and Drug Administration (FDA) Kalydeco (ivacaftor) is a medication prescribed for individuals with cystic fibrosis (CF) who are 4 months of age and older and possess at least one CF gene mutation that responds to Kalydeco treatment.

Buy Clenbuterol Harasawa Online

$102.85
(0 Reviews)
DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS) MANUFACTURER: Harasawa USAGE: Oral MEDICINE APPROVED BY: Pharmaceuticals and Medical Devices Agency (PMDA) Clenbuterol, a medication employed in the management of individuals afflicted with bronchial asthma, chronic bronchitis, emphysema, acute bronchitis, or stress urinary incontinence, has diverse applications in the medical field. Notably, physicians occasionally opt for Clenbuterol's off-label use in the treatment of patients grappling with ALS (Amyotrophic Lateral Sclerosis). It's worth mentioning that Clenbuterol was previously recognized by its brand name, TONIL (clenbuterol).

Back to Top
Product has been added to your cart